FANNY NNABUIKE: Open Payments
NPI 1992207930 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $503 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Validus Pharmaceuticals LLC | 1 | $18 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, REXULTI, EQUETRO, Subvenite.
Industry payments across TX — which companies pay providers there.
